Date:1/28/2010

0.1 2.7 Certificates of deposit 66.4 - Receivables, net 751.4 732.8 Inventories, net 913.2 928.3 Other current assets 315.2 302.2 ----- ----- Total current assets 2,738.0 2,178.6 Property, plant and equipment, net 1,221.7 1,264.1 Goodwill 2,783.5 2,774.8 Intangible assets, net 858.0 872.1 Other assets 184.3 149.4 ----- ----- Total Assets $7,785.5 $7,239.0 ======== ======== Liabilities and Shareholders' Equity Current liabilities $690.7 $771.1 Other long-term liabilities 328.5 353.9 Long-term debt 1,127.6 460.1 Shareholders' equity 5,638.7 5,653.9 ------- ------- Total Liabilities and Shareholders' Equity $7,785.5 $7,239.0 ======== ======== ZIMMER HOLDINGS, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS
'/>"/>

SOURCE Zimmer Holdings, Inc. Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Related medicine technology :

1. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Full-Year 2009 Results
2. Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
3. Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference
4. Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes
5. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
6. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
7. Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results
8. Lilly Reports Fourth-Quarter and Full-Year 2009 Results
9. P&G Reports Accelerated Sales and Unit Volume Growth
10. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
11. Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results